Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-08 4:29 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 2,301,628 5.3% | 882,953 (+62.24%) | View |
| 2024-06-03 4:30 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Adage Capital Management L.P. | 4,210,429 9.99% | 4,210,429 (New Position) | View |
| 2024-05-13 5:03 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | SUVRETTA CAPITAL MANAGEMENT LLC | 3,685,503 9.3% | 3,685,503 (New Position) | View |
| 2024-05-09 3:06 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | JANUS HENDERSON GROUP PLC JHG | 2,380,667 6.1% | 2,380,667 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Nantahala Capital Management LLC | 2,499,781 9.9% | 1,140,094 (+83.85%) | View |
| 2024-02-14 4:20 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Point72 Asset Management L.P. | 1,649,740 6.4% | 499,092 (+43.37%) | View |
| 2024-02-14 4:15 pm Sale | 13G | ABEONA THERAPEUTICS INC. ABEO | EcoR1 Capital LLC | 1,086,956 4.2% | -698,707 (-39.13%) | View |
| 2024-02-14 2:38 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | ARMISTICE CAPITAL LLC | 1,301,114 4.99% | 195,114 (+17.64%) | View |
| 2024-02-12 5:23 pm Sale | 13G | ABEONA THERAPEUTICS INC. ABEO | Flynn James E | 869,565 3.39% | -869,565 (-50.00%) | View |
| 2024-01-10 4:22 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 1,418,675 5.7% | 56,576 (+4.15%) | View |
| 2023-12-04 4:09 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 1,362,099 5.5% | 1,362,099 (New Position) | View |
| 2023-07-06 4:31 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,249,994 15.32% | 1,918,834 (+144.15%) | View |
| 2023-02-14 5:05 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Nantahala Capital Management LLC | 1,359,687 7.9% | 1,359,687 (New Position) | View |
| 2023-02-14 4:20 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Point72 Asset Management L.P. | 1,150,648 7.4% | 189,778 (+19.75%) | View |
| 2023-02-14 11:49 am Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | ARMISTICE CAPITAL LLC | 1,106,000 6.44% | 1,106,000 (New Position) | View |
| 2023-02-10 09:58 am Unchanged | 13G | ABEONA THERAPEUTICS INC. ABEO | Flynn James E | 1,739,130 5.06% | 0 (Unchanged) | View |
| 2023-02-09 12:35 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,331,160 7.75% | 1,331,160 (New Position) | View |
| 2023-01-10 4:59 pm Sale | 13G | ABEONA THERAPEUTICS INC. ABEO | HIRSCHMAN ORIN | 652,174 3.8% | -139,644 (-17.64%) | View |
| 2022-11-16 4:47 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Flynn James E | 1,739,130 5.06% | 1,739,130 (New Position) | View |
| 2022-11-14 4:56 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | EcoR1 Capital LLC | 1,785,663 9.99% | 1,785,663 (New Position) | View |